Apnimed was founded in 2017 by Lawrence G. Miller and Luigi Taranto Montemurro. Apnimed has not officially endorsed a plan to participate in an IPO.
Apnimed is a pharmaceutical company developing oral pharmacologic treatments for obstructive sleep apnea and other related disorders. Per Forge data, Apnimed has raised a total of $207.8 million in funding over 5 rounds. Their latest funding was raised on Dec 23, 2022, from a Series C round. Key investors include Sectoral Asset Management, Morningside Venture Partners, and Alpha Wave Ventures.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/22/2022 | Series C-3 | $79.75MM | $xx.xx | $36.66B | Alpha Wave Ventures, Sectoral Asset Management, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
7,184,033
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Sectoral Asset Management, Seligman Investments, Tao Capital Partners
|
||||||
05/04/2022 | Series C-2 | $25MM | $xx.xx | $26.87B | Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,252,042
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners
|
||||||
05/04/2022 | Series C-1 | $37.5MM | $xx.xx | $26.87B | Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,222,581
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Alpha Wave Ventures, Morningside Ventures, Nexpoint, Sectoral Asset Management, Seligman Investments, Tao Capital Partners
|
||||||
03/25/2021 | Series B | $25MM | $xx.xx | $15.62B | Morningside Venture, Seligman Investments, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
2,818,964
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Morningside Venture, Seligman Investments, Tao Capital Partners
|
||||||
03/31/2020 | Series A-2 | $15MM | $xx.xx | $9.89B | Morningside Venture | |
Price per Share
$xx.xx
Shares Outstanding
2,349,108
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Morningside Venture
|
||||||
06/25/2018 | Series A | $25.77MM | $xx.xx | $5.73B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,397,935
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|